163 related articles for article (PubMed ID: 22645077)
1. Genetic variation in insulin pathway genes and distal colorectal adenoma risk.
Levine AJ; Ihenacho U; Lee W; Figueiredo JC; Vandenberg DJ; Edlund CK; Davis BD; Stern MC; Haile RW
Int J Colorectal Dis; 2012 Dec; 27(12):1587-95. PubMed ID: 22645077
[TBL] [Abstract][Full Text] [Related]
2. Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study.
Levine AJ; Lee W; Figueiredo JC; Conti DV; Vandenberg DJ; Davis BD; Edlund CK; Henning SM; Heber D; Stern MC; Haile RW
Cancer Causes Control; 2011 Apr; 22(4):541-52. PubMed ID: 21274745
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance-related genes and advanced left-sided colorectal adenoma.
Gunter MJ; Hayes RB; Chatterjee N; Yeager M; Welch R; Schoen RE; Yakochi L; Schatzkin A; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):703-8. PubMed ID: 17416760
[TBL] [Abstract][Full Text] [Related]
4. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk.
Corral R; Lewinger JP; Joshi AD; Levine AJ; Vandenberg DJ; Haile RW; Stern MC
PLoS One; 2013; 8(8):e71211. PubMed ID: 23951112
[TBL] [Abstract][Full Text] [Related]
6. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
[TBL] [Abstract][Full Text] [Related]
7. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
[TBL] [Abstract][Full Text] [Related]
8. Genetic Colorectal Cancer and Adenoma Risk Variants Are Associated with Increasing Cumulative Adenoma Counts.
Sullivan BA; Qin X; Redding TS; Gellad ZF; Stone A; Weiss D; Madison AN; Sims KJ; Williams CD; Lieberman D; Hauser ER; Provenzale D
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2269-2276. PubMed ID: 32928932
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk.
Ochs-Balcom HM; Vaughn CB; Nie J; Chen Z; Thompson CL; Parekh N; Tracy R; Li L
Cancer Causes Control; 2014 Feb; 25(2):161-70. PubMed ID: 24194259
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer.
Gargallo CJ; Lanas Á; Carrera-Lasfuentes P; Ferrandez Á; Quintero E; Carrillo M; Alonso-Abreu I; García-Gonzalez MA
Int J Cancer; 2019 Feb; 144(3):489-502. PubMed ID: 30194776
[TBL] [Abstract][Full Text] [Related]
11. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.
Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI
Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.
Huang BZ; Tsilidis KK; Smith MW; Hoffman-Bolton J; Visvanathan K; Platz EA; Joshu CE
Mol Carcinog; 2018 Oct; 57(10):1278-1288. PubMed ID: 29802748
[TBL] [Abstract][Full Text] [Related]
13. Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia.
LeRoy EC; Moore JH; Hu C; Martínez ME; Lance P; Duggan D; Thompson PA
Hum Genet; 2011 May; 129(5):503-12. PubMed ID: 21221997
[TBL] [Abstract][Full Text] [Related]
14. Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.
Han SS; Sue LY; Berndt SI; Selhub J; Burdette LA; Rosenberg PS; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):417-27. PubMed ID: 22253295
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.
Poole EM; Hsu L; Xiao L; Kulmacz RJ; Carlson CS; Rabinovitch PS; Makar KW; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):547-57. PubMed ID: 20086108
[TBL] [Abstract][Full Text] [Related]
16. Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study.
Skjelbred CF; Saebø M; Nexø BA; Wallin H; Hansteen IL; Vogel U; Kure EH
BMC Cancer; 2006 Jul; 6():175. PubMed ID: 16817948
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
Gong Z; Bostick RM; Xie D; Hurley TG; Deng Z; Dixon DA; Zhang J; Hebert JR
Int J Colorectal Dis; 2009 Jun; 24(6):647-54. PubMed ID: 19205707
[TBL] [Abstract][Full Text] [Related]
18. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps.
Wernli KJ; Newcomb PA; Wang Y; Makar KW; Shadman M; Chia VM; Burnett-Hartman A; Wurscher MA; Zheng Y; Mandelson MT
Growth Horm IGF Res; 2010 Aug; 20(4):305-9. PubMed ID: 20580999
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variant on BMP4 contributes to colorectal adenoma and cancer: A meta-analysis based on 15 studies.
Zhou L; Xie J; Gu EL; Huang Y; Qu Y; Xu AP; Zhu Y; Wang H
Cytokine; 2015 Apr; 72(2):154-9. PubMed ID: 25647270
[TBL] [Abstract][Full Text] [Related]
20. DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.
Gao Y; Hayes RB; Huang WY; Caporaso NE; Burdette L; Yeager M; Chanock SJ; Berndt SI
Carcinogenesis; 2011 Jun; 32(6):882-7. PubMed ID: 21504893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
